Astrazeneca Pharma India's Stock Sees Positive Trend, Outperforms Sector by 6.77%

Astrazeneca Pharma India, a midcap pharmaceutical company, has seen a positive trend in its stock performance on May 24th, 2024. The stock gained 7.64%, outperforming the sector by 6.77%. This comes after two consecutive days of fall, indicating a possible trend reversal. The stock also touched an intraday high of Rs 6064.7, showing a strong upward movement. Astrazeneca Pharma India is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bullish trend. In comparison to the Sensex, Astrazeneca Pharma India has outperformed with a 1-day performance of 7.72% versus Sensex's 0.22%. Over the past month, the stock has shown a 15.91% increase, while the Sensex has only seen a 2.34% increase. MarketsMOJO has given a 'Hold' call for Astrazeneca Pharma India's stock, suggesting a neutral stance. This midcap company in the pharmaceutical industry has shown a strong performance and is expected to continue its positive trend. Investors should keep an eye on this stock for potential opportunities.